Polyneuron Pharmaceuticals AG

Swiss Biotech Association

Member

Polyneuron is a pharmaceutical company with a proprietary Antibody-Catch™ platform that enables the chemical design of injectable glycopolymers. These glycopolymers are designed to selectively eliminate autoantibodies in autoimmune disease patients, while leaving the immune system intact.

http://polyneuron.com/
+41 61 633 30 70
info@polyneuron.com
Dr. Ruben Herrendorff

Location

Hochbergerstrasse 60c, 4057 Basel, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2014
Number of employees in Switzerland

1-9

Key business

Core competencies

You may also be interested in

Sintetica SA

Sintetica is a pharmaceutical company delivering injectable medicines to patients worldwide, through innovative science and excellence in development, production and marketing. The multicultural high-performing organization is built to support both the national growth and the global expansion.
Mendrisio

Member

Labatec Pharma SA

Labatec is a privately owned Swiss-based pharmaceutical company with more than 50 years of experience in delivering high quality products to the European and Emerging Markets. Covering both the hospital and retail sectors, we have a portfolio of over 65 products and a growing geographic footprint.
Meyrin

Member

GlycoEra AG

GlycoEra leverages its control over natural glycan-mediated pathways to advance novel drugs using its propriety platform, the CustumGlycan Platform. GlycoEra develops first in class therapeutics in inflammatory disease, autoimmune disorder and immuno-oncology indications.
8952 Schlieren

Member